Health

Health Check: Neuren Sees Promise in the US Rett Syndrome Market

Neuren’s US Partner Acadia Reports Sales Growth and Future Prospects Neuren Pharmaceuticals (ASX:NEU) has seen positive developments in its partnership with Acadia Pharmaceuticals, which reported a 14% increase in quarterly net sales. The Nasdaq-listed company recorded sales of US$96.1 million for the quarter, showing continued growth for the third consecutive quarter. This success is attributed […]
  • maskobus
  • Aug 10, 2025